Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
Ruth J. Pepper(University College Hospital), Thomas Cairns(Hammersmith Hospital), Jeremy Levy(Imperial College Healthcare NHS Trust), Cliona Kirwan(Hammersmith Hospital), Liz Lightstone(Imperial College London), David Taube(Hammersmith Hospital), Charles D. Pusey(Imperial College Healthcare NHS Trust), Megan Griffith(Imperial College Healthcare NHS Trust)
Cited by 156
Related Papers
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
|Annals of the Rheumatic Diseases|2013|454
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
|Annals of the Rheumatic Diseases|2016|231
CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis
|Journal of Clinical Investigation|2000|176